Literature DB >> 33686287

Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2.

Leentje Persoons1, Els Vanstreels1, Sander Jansen1, Jim Baggen2, Dominique Van Looveren1,3, Bram Boeckx4,5, Vincent Geudens6, Julie De Man1, Dirk Jochmans1, Joost Wauters7, Els Wauters6, Bart M Vanaudenaerde6, Diether Lambrechts4,5, Johan Neyts1, Kai Dallmeier1, Hendrik Jan Thibaut1,3, Maarten Jacquemyn1, Piet Maes8, Dirk Daelemans9.   

Abstract

The ongoing COVID-19 pandemic has caused a global economic and health crisis. To identify host factors essential for coronavirus infection, we performed genome-wide functional genetic screens with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human coronavirus 229E. These screens uncovered virus-specific as well as shared host factors, including TMEM41B and PI3K type 3. We discovered that SARS-CoV-2 requires the lysosomal protein TMEM106B to infect human cell lines and primary lung cells. TMEM106B overexpression enhanced SARS-CoV-2 infection as well as pseudovirus infection, suggesting a role in viral entry. Furthermore, single-cell RNA-sequencing of airway cells from patients with COVID-19 demonstrated that TMEM106B expression correlates with SARS-CoV-2 infection. The present study uncovered a collection of coronavirus host factors that may be exploited to develop drugs against SARS-CoV-2 infection or future zoonotic coronavirus outbreaks.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33686287     DOI: 10.1038/s41588-021-00805-2

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  1 in total

1.  Comprehensive Integration of Single-Cell Data.

Authors:  Tim Stuart; Andrew Butler; Paul Hoffman; Christoph Hafemeister; Efthymia Papalexi; William M Mauck; Yuhan Hao; Marlon Stoeckius; Peter Smibert; Rahul Satija
Journal:  Cell       Date:  2019-06-06       Impact factor: 41.582

  1 in total
  50 in total

1.  Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs.

Authors:  Caroline Goujon; Antoine Rebendenne; Priyanka Roy; Boris Bonaventure; Ana Chaves Valadao; Lowiese Desmarets; Yves Rouillé; Marine Tauziet; Mary Arnaud-Arnould; Donatella Giovannini; Yenarae Lee; Peter DeWeirdt; Mudra Hegde; Francisco Garcia de Gracia; Joe McKellar; Mélanie Wencker; Jean Dubuisson; Sandrine Belouzard; Olivier Moncorgé; John Doench
Journal:  Res Sq       Date:  2021-05-27

2.  Orthogonal genome-wide screens of bat cells identify MTHFD1 as a target of broad antiviral therapy.

Authors:  Danielle E Anderson; Jin Cui; Qian Ye; Baoying Huang; Ya Tan; Chao Jiang; Wenhong Zu; Jing Gong; Weiqiang Liu; So Young Kim; Biao Guo Yan; Kristmundur Sigmundsson; Xiao Fang Lim; Fei Ye; Peihua Niu; Aaron T Irving; Haoyu Zhang; Yefeng Tang; Xuming Zhou; Yu Wang; Wenjie Tan; Lin-Fa Wang; Xu Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-28       Impact factor: 11.205

3.  Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs.

Authors:  Boris Bonaventure; Ana Luiza Chaves Valadão; Antoine Rebendenne; Priyanka Roy; Lowiese Desmarets; Mary Arnaud-Arnould; Yves Rouillé; Marine Tauziet; Donatella Giovannini; Jawida Touhami; Yenarae Lee; Peter DeWeirdt; Mudra Hegde; Serge Urbach; Khadija El Koulali; Francisco Garcia de Gracia; Joe McKellar; Jean Dubuisson; Mélanie Wencker; Sandrine Belouzard; Olivier Moncorgé; John G Doench; Caroline Goujon
Journal:  Nat Genet       Date:  2022-07-25       Impact factor: 41.307

4.  VMP1 and TMEM41B are essential for DMV formation during β-coronavirus infection.

Authors:  Mingming Ji; Meng Li; Long Sun; Hongyu Zhao; Ying Li; Lulu Zhou; Zhenni Yang; Xin Zhao; Wenyan Qu; Hanbing Xue; Ze Zheng; Yiming Li; Hongyu Deng; Yan G Zhao
Journal:  J Cell Biol       Date:  2022-05-10       Impact factor: 8.077

Review 5.  Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development.

Authors:  Man Teng; Yongxiu Yao; Venugopal Nair; Jun Luo
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 6.  SARS-CoV-2 cell entry and targeted antiviral development.

Authors:  Zinuo Chen; Ruikun Du; Jazmin M Galvan Achi; Lijun Rong; Qinghua Cui
Journal:  Acta Pharm Sin B       Date:  2021-05-13       Impact factor: 11.413

Review 7.  Regulation of ER-derived membrane dynamics by the DedA domain-containing proteins VMP1 and TMEM41B.

Authors:  Yutaro Hama; Hideaki Morishita; Noboru Mizushima
Journal:  EMBO Rep       Date:  2022-01-19       Impact factor: 8.807

8.  Severe COVID-19 in Alzheimer's disease: APOE4's fault again?

Authors:  Nian Xiong; Martin R Schiller; Jingwen Li; Xiaowu Chen; Zhicheng Lin
Journal:  Alzheimers Res Ther       Date:  2021-06-12       Impact factor: 6.982

9.  Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.

Authors:  Leentje Persoons; Evelien Vanderlinden; Laura Vangeel; Xinyu Wang; Nguyen Dan Thuc Do; Shi-Yan Caroline Foo; Pieter Leyssen; Johan Neyts; Dirk Jochmans; Dominique Schols; Steven De Jonghe
Journal:  Antiviral Res       Date:  2021-07-01       Impact factor: 5.970

10.  Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.

Authors:  Nir Drayman; Jennifer K DeMarco; Krysten A Jones; Saara-Anne Azizi; Heather M Froggatt; Kemin Tan; Natalia Ivanovna Maltseva; Siquan Chen; Vlad Nicolaescu; Steve Dvorkin; Kevin Furlong; Rahul S Kathayat; Mason R Firpo; Vincent Mastrodomenico; Emily A Bruce; Madaline M Schmidt; Robert Jedrzejczak; Miguel Á Muñoz-Alía; Brooke Schuster; Vishnu Nair; Kyu-Yeon Han; Amornrat O'Brien; Anastasia Tomatsidou; Bjoern Meyer; Marco Vignuzzi; Dominique Missiakas; Jason W Botten; Christopher B Brooke; Hyun Lee; Susan C Baker; Bryan C Mounce; Nicholas S Heaton; William E Severson; Kenneth E Palmer; Bryan C Dickinson; Andrzej Joachimiak; Glenn Randall; Savaş Tay
Journal:  Science       Date:  2021-07-20       Impact factor: 63.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.